Is there a need to identify novel tumour antigens as targets for immunotherapy clinical trials for the removal of minimal residual disease in haematological malignancies?
- Barbara Guinn
Research Output:
Contribution to journal
Article
Peer-reviewOpen access
Sustainable Development Goals
- SDG 3 Good Health and Well
Abstract
Publication Information
Output type
Research Output:
Contribution to journal
Article
Peer-reviewOriginal language
EnglishPages from-to (Number of pages)
Pages 24-26Journal (Volume, Issue Number)
International journal of hematology research (Volume 1)Publication milestones
- Published - 01/07/2015
Publication status
Published - 01/07/2015
Publication IDs
- handle.net: 10547/578850
